Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:NHWK

NightHawk Biosciences (NHWK) Stock Price, News & Analysis

NightHawk Biosciences logo

About NightHawk Biosciences Stock (NYSE:NHWK)

Key Stats

Today's Range
N/A
50-Day Range
$0.26
$0.50
52-Week Range
N/A
Volume
173,100 shs
Average Volume
97,242 shs
Market Capitalization
$10.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NHWK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NightHawk Biosciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NHWK Stock News Headlines

SCPXD Scorpius Holdings, Inc.
Scorpius Holdings GAAP EPS of -$1.74
Stunning new initiative unfolding in the White House?
what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for yourself. Once you see what’s unfolding behind the scenes, you’ll understand why I rushed this interview and opportunity to you today.tc pixel
See More Headlines

NHWK Stock Analysis - Frequently Asked Questions

NightHawk Biosciences, Inc. (NYSE:NHWK) posted its quarterly earnings data on Tuesday, November, 9th. The biopharmaceutical company reported ($0.30) earnings per share for the quarter, missing analysts' consensus estimates of ($0.29) by $0.01. The biopharmaceutical company earned $0.50 million during the quarter, compared to analysts' expectations of $0.57 million. NightHawk Biosciences had a negative trailing twelve-month return on equity of 91.62% and a negative net margin of 2,333.27%.

NightHawk Biosciences's stock reverse split on Friday, December 11th 2020.The 1-7 reverse split was announced on Thursday, December 10th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Friday, December 11th 2020. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that NightHawk Biosciences investors own include Inovio Pharmaceuticals (INO), Sorrento Therapeutics (SRNE), Meta Platforms (META), Vaxart (VXRT), Alibaba Group (BABA), NVIDIA (NVDA) and Novavax (NVAX).

Company Calendar

Last Earnings
11/09/2021
Today
9/19/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSE:NHWK
CIK
1476963
Fax
N/A
Employees
77
Year Founded
2008

Profitability

EPS (Trailing Twelve Months)
($1.99)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$43.44 million
Net Margins
-2,333.27%
Pretax Margin
-2,546.97%
Return on Equity
-91.62%
Return on Assets
-56.48%

Debt

Debt-to-Equity Ratio
0.27
Current Ratio
0.99
Quick Ratio
0.99

Sales & Book Value

Annual Sales
$6.38 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.82 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
26,080,000
Free Float
21,935,000
Market Cap
$10.78 million
Optionable
Optionable
Beta
0.19

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NYSE:NHWK) was last updated on 9/19/2025 by MarketBeat.com Staff
From Our Partners